4//SEC Filing
Lowdell Mark William 4
Accession 0001213900-25-117309
CIK 0001711754other
Filed
Dec 1, 7:00 PM ET
Accepted
Dec 2, 4:43 PM ET
Size
5.7 KB
Accession
0001213900-25-117309
Insider Transaction Report
Form 4
Inmune Bio, Inc.INMB
Lowdell Mark William
Chief Scientific Officer
Transactions
- Award
Option (right to buy)
2025-12-01+600,000→ 600,000 totalExercise: $1.48Exp: 2035-11-23→ Common Stock (600,000 underlying)
Footnotes (1)
- [F1]Granted pursuant to the Issuer's Second Amended and Restated 2021 Stock Incentive Plan. One-fourth (1/4) of the option will vest 12 months from the date of grant and thereafter the remaining unvested option will become vested and exercisable pro rata on a monthly basis over three (3) years (1/36 per month) until the option is 100% vested which shall occur on the four-year anniversary of the date of grant.
Documents
Issuer
Inmune Bio, Inc.
CIK 0001711754
Entity typeother
Related Parties
1- filerCIK 0001767037
Filing Metadata
- Form type
- 4
- Filed
- Dec 1, 7:00 PM ET
- Accepted
- Dec 2, 4:43 PM ET
- Size
- 5.7 KB